Stingray Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 7

EPO Patents = 3

Forward Citations = 2

Loading Chart...

10 inventors (with patents filed for the assignee):

Alexis Weston (7 out of 7 patents)

Mohan Rao Kaadige (7 out of 7 patents)

Sunil Sharma (7 out of 21 patents)

4. Trason Thode (6 out of 6 patents)

5. Srinivas Rao Kasibhatla (4 out of 26 patents)

6. Hariprasad Vankayalapati (3 out of 51 patents)

7. Raman Kumar Kalakuntla (2 out of 2 patents)

8. Xiaohui Liu (1 out of 11 patents)

9. Gurusankar Ramamoorthy (1 out of 1 patent)

10. Raman Kumar Kalakuntla (0 patent)

7 patents: Sort by Forward Citations

1. 12741963 - Imidazole compounds as inhibitors of ENPP1 (2026-09-22),

2. 12653835 - Phosphonates as inhibitors of ENPP1 and CDNP (2026-06-16),

3. 12152015 - Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereof (2024-11-26),

4. 11591313 - Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereof (2023-02-28),

5. 11407729 - Quinoline and quinazoline compounds and methods of use thereof (2022-08-09),

6. 11142524 - Substituted-3H-imidazo[4,5-c]pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics (2021-10-12),

7. 10689376 - Substituted-3H-imidazo [4,5-c] pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics (2020-06-23),

Company Overview

Stingray Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for cancer. With a team of experienced researchers and scientists, Stingray is dedicated to advancing precision oncology through innovative drug discovery and development. Their cutting-edge approach aims to address unmet medical needs and improve patient outcomes in the fight against cancer.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

7 Patents

#632 in Houston, TX

#2,558 in Texas

#40,006 in US

Houston, TX, United States of America

Stingray Therapeutics, Inc.

Forward Citations = 2

10 inventors:

Alexis Weston (7 out of 7 patents)

Mohan Rao Kaadige (7 out of 7 patents)

Sunil Sharma (7 out of 21 patents)

4. Trason Thode (6 out of 6 patents)

5. Srinivas Rao Kasibhatla (4 out of 26 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Stingray Therapeutics, Inc.. Retrieved from https://idiyas.com/company/stingray-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]